Kayne Anderson Rudnick Investment Management
ONC

Kayne Anderson Rudnick Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$677K Buy
2,279
+173
+8% +$56K ﹤0.01% 409
2025
Q4 		$640K Buy
2,106
+122
+6% +$39.9K ﹤0.01% 427
2025
Q3 		$676K Buy
1,984
+349
+21% +$106K ﹤0.01% 413
2025
Q2 		$396K Buy
1,635
+1,480
+955% +$363K ﹤0.01% 449
2025
Q1 		$42.2K Buy
+155
New +$36.2K ﹤0.01% 595
2024
Q1 		– Sell
-1
Closed -$180 – 1004
2023
Q4 		$180 Hold
1
– – ﹤0.01% 928
2023
Q3 		$180 Hold
1
– – ﹤0.01% 840
2023
Q2 		$178 Hold
1
– – ﹤0.01% 840
2023
Q1 		$216 Buy
+1
New +$240 ﹤0.01% 714
2022
Q1 		– Sell
-1
Closed – – 735
2021
Q4 		$0 Buy
+1
New +$338 ﹤0.01% 669

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return